Terms: = Pancreatic cancer AND CARS, P49589, 833, ENSG00000110619 AND Staging
5 results:
1. Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response.
Barrak D; Villano AM; Villafane-Ferriol N; Stockton LG; Hill MV; Deng M; Handorf EA; Reddy SS
Eur J Surg Oncol; 2022 Jun; 48(6):1356-1361. PubMed ID: 35016837
[TBL] [Abstract] [Full Text] [Related]
2. A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study.
Zhang H; Gao C; Chen J; Wu S; Bai J; Yin T
J Transl Med; 2021 Dec; 19(1):525. PubMed ID: 34952605
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms.
Liao T; Su T; Huang L; Li B; Feng LH
Scand J Gastroenterol; 2022 Jan; 57(1):85-90. PubMed ID: 34592854
[TBL] [Abstract] [Full Text] [Related]
4. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract] [Full Text] [Related]
